| Class / Patent application number | Description | Number of patent applications / Date published |
|---|
| 540465000 | Heavy metal or aluminum containing | 29 |
| 20090131656 | METHODS OF NANOASSEMBLY OF A FRACTAL POLYMER AND MATERIALS FORMED THEREBY - The invention relates to the formation of synthesized fractal constructs and the methods of chemical self-assembly for the preparation of a non-dendritic, nano-scale, fractal constructs or molecules. More particularly, the invention relates to fractal constructs formed by molecular self-assembly, to create synthetic, nanometer-scale fractal shapes. In an embodiment, a nanoscale Sierpinski hexagonal gasket is formed. This non-dendritic, perfectly self-similar fractal macromolecule is comprised of bisterpyridine building blocks that are bound together by coordination to 36 Ru and 6 Fe ions to form a nearly planar array of increasingly larger hexagons around a hollow center. | 05-21-2009 |
| 20090156801 | BIOMOLECULE LABELING REACTANTS BASED ON AZACYCLOALKANES AND CONJUGATES DERIVED THEREOF - This invention concerns novel labeling reactants based on azacycloalkanes, wherein a suitable group is linked to the molecule allowing introduction of the said molecules to bioactive molecules in solution or on solid phase. | 06-18-2009 |
| 20090240050 | Method Of Preparing Macrocylic Metal Cyanine Compound - A method of preparing a macrocyclic metal cyanine. The method comprises the step of providing a corresponding macrocyclic metal-free cyanine compound dissolved in a solvent and adding a metal reagent thereto. The metal reagent is highly soluble in the solvent and typically comprises one or more organic ligands. | 09-24-2009 |
| 20090306368 | POLYNUCLEAR COMPLEX - A polynuclear complex having two or more metal atoms and/or metal ions per one ligand of the general formula (I): | 12-10-2009 |
| 20090318681 | METAL COMPLEX, AND USE THEREOF - Provided is a metal complex represented by the following formula (A-1) or (B-1) as a metal complex useful for a redox reaction catalyst or some other article that is excellent in heat resistance and acid resistance: | 12-24-2009 |
| 20100184971 | METAL NANOPARTICLES, AN ELECTRODE USING THEM AND A PROCESS OF PREPARING METAL NANOPARTICLES - An object of the invention is to modify the surface of a metal nanoparticle with a cyclic phenylazomethine having a multi-ion sensing capability, thereby making the sensing of multiple substances possible. | 07-22-2010 |
| 20100292465 | CATALYSTS CONTAINING N-HETEROCYCLIC CARBENES FOR ENANTIOSELECTIVE SYNTHESIS - Novel N-heterocyclic carbene ligand precursors, N-heterocyclic carbene ligands and N-heterocyclic metal-carbene complexes are provided. Metal-carbene complexes comprising N-heterocyclic carbene ligands can be chiral, which are useful for catalyzing enantioselective synthesis. Methods for the preparation of the N-heterocyclic carbene ligands and N-heterocyclic metal-carbene complexes are given. | 11-18-2010 |
| 20110028713 | AZA COMPOUNDS AND PRODUCTION METHOD THEREOF, AND METAL COMPLEXES AS MRI CONTRAST AGENTS - A core of a cyclic structure represented by (—N—(CH | 02-03-2011 |
| 20110112289 | COMPOUNDS USEFUL AS LIGANDS AND PARTICULARLY AS ORGANIC CHROMOPHORES FOR COMPLEXING LANTHANIDES AND APPLICATIONS THEREOF - The invention relates to the use of compounds comprising at least one 2-(1H-tetrazol-5-yl)pyridine unit, of formula (I) below: | 05-12-2011 |
| 20110118459 | HIGH PERFORMANCE LUMINESCENT COMPOUNDS - Embodiments relate to the field of chemistry and biochemistry, and, more specifically, to novel near-infrared dyes that are photostable and resistant to quenching. The dyes belong to a novel family of squaraine rotaxanes, and they are particularly well-suited for use in biological applications. Also disclosed are methods of synthesizing the dyes and methods of using the dyes. | 05-19-2011 |
| 20120202990 | Method For Producing Bridged Manganese Complexes Of Triazacyclononane - The invention relates to a method for producing manganese complex compounds of the general formula (1), wherein M, X, L, z, Y and q are defined as in claim | 08-09-2012 |
| 20130053554 | PREPARATION OF BLEACHING CATALYSTS - The present invention concerns synthesising manganese complexes in essentially non-aqueous solutions. | 02-28-2013 |
| 20130116429 | Gadobutrol Preparation in a One-Pot Process by means of DMF Acetal and N-Methylimidazole - A process is described for preparation of the gadolinium complex of N-(1-hydroxymethyl-2,3-dihydroxypropyl)-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane “gadobutrol=Gadovist®” in a one-pot process by means of DMF acetal and N-methylimidazole. Gadovist is a gadolinium-containing contrast agent for nuclear spin tomography and has been approved since 2000 in Germany in the indication “contrast amplification in cranial and spinal magnetic resonance tomography”. | 05-09-2013 |
| 20130231475 | MRI CONTRAST AGENT HAVING GADOLINIUM COMPLEX - The present invention relates to a magnetic resonance imaging (MRI) contrast agent including a gadolinium complex, more particularly to a DO3A-tranexamic acid or its ester compound, which is represented by the Chemical Formula 1. A DO3A-tranexamic acid or its ester compound may be prepared according to the present invention and a gadolinium complex may be prepared using the compound. An MRI contrast agent including the gadolinium complex prepared according to the present invention as an active ingredient has higher relaxivity as compared to the currently commercially available contrast agent. In addition, the MRI contrast agent according to the present invention has bifunctionality of liver-specific and blood-pool contrasting effect. Accordingly, since the MRI contrast agent including the gadolinium complex according to the present invention satisfies the key properties required for a contrast agent for MRI, it can be widely used as an MRI contrast agent and can provide enhanced contrasting effect as compared to the existing contrast agent. | 09-05-2013 |
| 20140073780 | MULTIMERIC DUAL-MODALITY BREAST CANCER DIAGNOSTIC AGENTS - The present invention describes dual-modality probes. In particular, the present invention discloses hydroxyapatite specific multimeric bisphosphonate dual-modality MRI and optical probes. | 03-13-2014 |
| 20140142298 | SYNTHESIS OF IMIDAZO[1,2-a]PYRAZIN-4-IUM SALTS FOR THE SYNTHESIS OF 1,4,7-TRIAZACYCLONONANE (TACN) AND N- AND/OR C-FUNCTIONALIZED DERIVATIVES THEREOF - The present invention embodiments relate to a compound with formula (V′) | 05-22-2014 |
| 20140148596 | Covalent Organic Frameworks and Methods of Making Same - Crystalline COFs comprising a phthalocyanine moiety and a boron-containing multifunctional linking group joined by boronate ester bonds. A method for making crystalline COFs comprising Lewis acid catalyzed formation of boronate ester bonds between protected catechol subunits and multifunctional linkers comprising boronic acid groups. The COFs can be used in applications such as, for example, electronic devices. | 05-29-2014 |
| 20140171637 | PROCESS FOR THE PREPARATION OF COMPLEXES OF 68GA - A process for the preparation of complexes containing | 06-19-2014 |
| 20140179918 | METALLOCORROLES - Metallocorrole complexes of third row transition metals (see Formula I below) may be used as therapeutic agents, catalysts, components of oxygen detectors, and components of light emitting diodes. In particular, metallocorrole complexes of third row transition metals may be used as improved photosenitizers in photodynamic therapy; as improved catalysts in aziridination, epoxidation, and water splitting reactions; as improved in vivo imaging agents; and as improved components in the emissive layer of OLEDs. Due to their strongly sigma-donating nature, corroles are able to stabilize third row transition metals in high oxidation states. Third row transition metals are significantly more electropositive than their first and second row counterparts and may therefore act as improved catalysts. In addition, the high spin-orbit coupling constants of third row transition metals may lead to easier singlet-triplet inter-system crossing in the excited state, which in turn may allow for long-wavelength phosphorescence that is desirable for many applications. | 06-26-2014 |
| 20140275521 | Aza metal complexes - A core of a cyclic structure represented by (—N—(CH | 09-18-2014 |
| 20140323718 | CAGE AMINE LIGANDS FOR METALLO-RADIOPHARMACEUTICALS - The present invention relates to compounds that are useful as metal ligands and which can be bound to a biological entity such as a molecular recognition moiety and methods of making these compounds. Once the compounds that are bound to a biological entity are coordinated with a suitable metallic radionuclide, the coordinated compounds are useful as radiopharmaceuticals in the areas of radiotherapy and diagnostic imaging. The invention therefore also relates to methods of diagnosis and therapy utilising the radiolabelled compounds of the invention. | 10-30-2014 |
| 20150051392 | FUNCTIONALISATION OF CAGE AMINE LIGANDS FOR METALLO-RADIOPHARMACEUTICALS - The present invention relates to compounds that are useful as metal ligands and which contain a moiety capable of binding to a biological entity and methods of making these compounds. These compounds are of interest as they can be bound to a biological entity and then coordinated with a suitable metallic radionuclide. The coordinated compounds are useful as radiopharmaceuticals in the areas of radiotherapy and diagnostic imaging. | 02-19-2015 |
| 20150141640 | Sulfonic Esters Of Metal Oxides And Methods Of Their Use - The present invention is directed to sulfonic esters of metal oxides including those of formulas I and II: | 05-21-2015 |
| 20150368181 | RECYCLABLE CHIRAL CATALYST FOR ASYMMETRIC NITROALDOL REACTION AND PROCESS FOR THE PREPARATION THEREOF - The present invention relates to preparation of highly efficient chiral recyclable homogeneous catalysts generated in situ by the reaction of chiral oligomeric [H | 12-24-2015 |
| 20160024030 | PROCESS FOR PRODUCING 1,4,7,10-TETRAAZACYCLODODECANE-1,4,7,10-TETRAACETIC ACID AND COMPLEXES THEREOF - A process for producing 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) including salts and hydrates thereof of general formula (I) from the respective cyclen. | 01-28-2016 |
| 20160031910 | LANTHANIDE COMPLEXES COMPRISING AT LEAST TWO BETAINE GROUPS, WHICH CAN BE USED AS LUMINESCENT MARKERS - The present invention relates to luminescent lanthanide complexes including a chelating agent, formed with a macrocycle or a set of ligands, complexing a lanthanide ion Ln3+, wherein the chelating agent is substituted with at least two groups. The invention is most particularly applied to lanthanide complexes, the chelating agent of which is formed the with three ligands integrating a 2,6 pyridine-di(carboxylic acid) or is formed with a macrocycle having a 1,4,7 triazacyclononane structure. | 02-04-2016 |
| 20160141523 | LUMINESCENT COMPLEXES AND DISPLAY DEVICES - Cationic iridium III complexes including a ligand according to formula I are provided. The linking group Z is a hydrocarbylene linking group comprising at least two carbon atoms in a chain. Ligands according to formula I have increased rigidity about the central bond linking the two five membered rings by virtue of the linking group Z, when compared to previous biimidazole related ligands. Increased photoluminescence quantum yield may been obtained in cationic iridium III complexes provided with these ligands. | 05-19-2016 |
| 20160168178 | MULTIMERIC DUAL-MODALITY BREAST CANCER DIAGNOSTIC AGENTS | 06-16-2016 |
| 20160185803 | PROCESS FOR THE PREPARATION OF MACROCYCLIC POLYAZACARBOXYLATE LIGANDS AND CHELATES - The present disclosure relates generally to a process for the synthesis of 1,4,7,10-tetraazacyclododecane ligands, chelates, and derivatives thereof. In particular, the present disclosure is directed to a process for the synthesis of 1,4,7,10-tetraaza-1,4,7,10-tetrakis(carboxymethyl)cyclododecane (DOTA) ligands, corresponding DOTA-metal chelates, and various derivatives thereof. | 06-30-2016 |
